
03_11 Mesothelioma and a bit of Large Cell Neuroendocrine Carcinoma
1. Presentation, and considerations for regional mesothelioma 2. Systemic therapy options for advanced mesothelioma 3. Corticosteroids for pemetrexed, paclitaxel and docetaxel 4. A quick review on con...
12 Loka 202329min

03_10 Small cell lung cancer
1. Background on SCLC 2. Approach to treatment by stage 3. Emerging discussion on prophylactic cranial irradiation 4. Brief review of basket and umbrella trials Citations As always, citations, and sou...
17 Syys 202333min

03_09 Stage III NSCLC for the Medical Oncologist
1. Refresher on T+N staging for Stage III 2. Evidence for concurrent chemoradiation 3. PACIFIC Trial 4. Encourage cessation regardless of stage of Lung Cancer Citations As always, citations, and sou...
31 Elo 202327min

03_08 ADAURA Trial
1. Background on adjuvant EGFR therapy 2. Discussion of initial and updated results 3. Hazard Ratios and Context 4. When crossover and access limit generalizability Citations As always, citations, a...
16 Elo 202325min

03_07 (Neo)Adjuvant NSCLC
1. Considerations with surgery, radiation, rate of relapse 2. Adjuvant chemotherapy 3. Adjuvant immune checkpoint inhibition 4. Emerging neoadjuvant trial Citations As always, citations, and sources ...
27 Heinä 202324min

03_06 Driver Mutations in Advanced NSCLC
1. EGFR inhibitors 2. ALK inhibitors 3. Less common molecular targets 4. Role of KRAS inhibitors and evidence for sotorasib Citations As always, citations, and sources include education from our res...
7 Heinä 202334min

03_05 NSCLC metastatic without driver mutations
1. Evidence to support platinum doublets 2. The tale of pemetrexed 3. Immune checkpoint inhibitors alone and in combination 4. Second Line, approach in progression Citations As always, citations, an...
21 Kesä 202331min

03_04 Overview of Lung Cancer
1. Presentation and Work-up 2. Staging and how to memorize staging algorithms 3. SVC Syndrome, an oncologic emergency 4. Variations by histology and molecular mutations Citations As always, citation...
31 Touko 202325min



















